ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

New Understanding of drug Resistance Exciting Revolution

September 17, 1982

Sausville to lead clinical research at Maryland.

December 5, 2003

Lasker Awards Resume; ASCO Fall Conference Scheduled For October

September 21, 1990

Final Issue of ‘76

December 10, 1976

In Brief: Three Patients Evaluated For Gene Therapy; Revised Program Instructions Available

November 30, 1990

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982